Exploration of the natural process of medical abortion under the new international follow-up standard and research on methods to reduce the rate of curettage

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032260

Enrollment

Unknown

Registered

2020-04-24

Start date

2020-07-01

Completion date

Unknown

Last updated

2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

medical abortion

Interventions

group B:Misoprostol was used

group C:no intervention

group A:no intervention

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1) Chinese singleton pregnant women; (2) Patients with live fetus within 5-12 weeks of pregnancy who require medical abortion; (3) Patients who using misoprostol to expel embryos.

Exclusion criteria

Exclusion criteria: (1) Patients who are forbidden to use prostaglandin drugs, such as those with glaucoma, asthma and allergic constitution; (2) Patients with hysteromyoma, adenomyosis, uterine malformation, intrauterine device and intrauterine adhesion found by Uterine ultrasound; (3) Patients suffering from heart, liver and kidney diseases and adrenocortical insufficiency.

Design outcomes

Primary

Measure	Time frame
Blood HCG, endometrial thickness, intrauterine residual volume and blood flow;	—

Countries

China

Contacts

Public ContactWu Cailin

The University of Hong Kong-Shenzhen Hospital

wucailinmail@126.com+86 13688815596

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026